Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App Credit Cards
Go PRO Now
Open App
you are here:
Success
Alert
Please select a Day.
Info

Alembic Pharmaceuticals Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
Add to

69/100
920.10
-4.50 (-0.49%)

As on 27 Oct, 2025 | 10:24

Open Trading A/c
Day Range
913.25
934.60
L H
52 Week Range
725.20
1156.00
L H
Volume
40,745
*
i

* BSE Market Depth (27 Oct 2025)

BUY SELL
QTY PRICE PRICE QTY
6 919.00 920.20 8
7 918.95 920.50 55
1 918.80 920.65 2
36 918.75 920.90 10
22 918.70 921.10 21
12820 Total Total 5600
Bid / Ask
919.00 / 920.20
Advance Chart
69/100
920.85
-2.85 (-0.31%)

As on 27 Oct, 2025 | 10:24

Open Trading A/c
Day Range
915.05
926.05
L H
52 Week Range
725.60
1152.60
L H
Volume
3,497
*
i

* BSE Market Depth (27 Oct 2025)

BUY SELL
QTY PRICE PRICE QTY
6 919.00 920.20 8
7 918.95 920.50 55
1 918.80 920.65 2
36 918.75 920.90 10
22 918.70 921.10 21
12820 Total Total 5600
Bid / Ask
919.00 / 920.20
Advance Chart
NSE
MC Essentials
76% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Superior Financial Strength, High Growth Trend Stock at Reasonable Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 934.60
          Previous Close 924.60
          Volume 40,745.00
          Value (Lacs) 374.89
            VWAP 918.91
          Beta
          Mkt Cap (Rs. Cr.) 18,086
          High 934.60
          Low 913.25
          UC Limit 1,109.50
          LC Limit 739.70
          52 Week High 1,156.00
          52 Week Low 725.20
          Face Value 2.00
          All Time High 1,303.90
          All Time Low 31.00
          20D Avg Volume 88,906
          20D Avg Delivery(%) 59.13
          Book Value Per Share 248.68
          Dividend Yield 1.20
          TTM EPS See historical trend 30.68 (-4.26% YoY)
          TTM PE See historical trend 29.99 (Average PE)
          P/B See historical trend 3.70 (Average P/B)
          Sector PE 39.75

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          69/100
          Superior Financial Strength, High Growth Trend Stock at Reasonable Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 20.41% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoters increased holding from 69.67% to 69.74% in Sep 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          9 out of 15 years Alembic Pharmaceuticals has given negative returns in October.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          October 43.40% (2013) 10.80% -9.10% (2023) -4.27% 1.76%
          Seasonality Analysis

          Forum

          Community Sentiments

          • 50% BUY
          • 50% SELL
          • 0% HOLD
          50%
          of moneycontrol users recommend buying Alembic Pharma

          What's your call on Alembic Pharma today?

          Read 0 investor views

          BUY SELL HOLD
          POST

          Broker Research

          05 Aug, 2025

          Motilal Oswal

          Reco Price 946.90 Target Price 990
          06 Aug, 2025

          ICICI Securities

          Reco Price 946.85 Target Price 900
          06 May, 2025

          Motilal Oswal

          Reco Price 887.60 Target Price 930
          04 Feb, 2025

          ICICI Securities

          Reco Price 880.35 Target Price 925
          06 Feb, 2025

          KRChoksey

          Reco Price 894.20 Target Price 909
          03 Feb, 2025

          Motilal Oswal

          Reco Price 908.50 Target Price 970
          Show More
          REFINITIV Report

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          No Data For Bulk Deals.

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Alembic Pharma 920.10 -0.49 18,085.77 29.99 3.70 11.23 -13.84 581 6,672 0.23
          Sun Pharma 1,694.30 -0.28 406,519.32 39.19 5.88 15.13 -8.93 10,980 52,578 0.03
          Divis Labs 6,495.00 -1.49 172,421.84 74.77 12.57 14.63 12.36 2,191 9,360 0.00
          Cipla 1,578.10 -0.40 127,473.50 23.64 4.49 16.90 5.99 5,291 27,547 0.00
          Torrent Pharma 3,587.00 0.16 121,400.38 60.64 16.18 25.17 4.49 1,911 11,516 0.40
          + See More

          About the Company

          Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. It was established in 1907. Alembic`s manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh.
          {"success":1,"data":{"address":{"address1":"Alembic Road,","address2":",","city":"Vadodra","state":"Gujarat","pincode":"390003","telephone1":"0265-6637000","telephone2":"","fax1":"0265-","fax2":"","email":"apl.investors@alembic.co.in","web":"http:\/\/www.alembicpharmaceuticals.com"},"management":[{"name":"Chirayu Amin","designation":"Chairman & CEO"},{"name":"Pranav Amin","designation":"Managing Director"},{"name":"Shaunak Amin","designation":"Managing Director"},{"name":"R K Baheti","designation":"Director - Finance & CFO"},{"name":"Jai Diwanji","designation":"Independent Director"}],"registrars":{"name":"MUFG Intime India Pvt. Ltd.","address1":"\u201cGeetakunj\u201d 1, Bhakti Nagar Society,\nBehind ABS To","address2":"","address3":"","address4":"","telephone":"0265-3566768","fax":"","email":"vadodara@linkintime.co.in","internet":"www.linkintime.co.in","city":"Vadodra","state":"Gujarat","pincode":"390015"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"533573","nseId":"APLLTD","series":"EQ","isinid":"INE901L01018"}}}

          • Registered Office

          • Registrars

          • Management

            • Chirayu Amin

              Chairman & CEO

            • Pranav Amin

              Managing Director

            • Shaunak Amin

              Managing Director

            • R K Baheti

              Director - Finance & CFO

            • Jai Diwanji

              Independent Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

            • Nifty 200

              No

          • Details

            • BSE:

              533573

            • NSE:

              APLLTD

            • Series

              EQ

            • ISIN

              INE901L01018

          Go to Top
          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347